Cargando…

Impact of season on the association between vitamin D levels at diagnosis and one-year remission in early Rheumatoid Arthritis

The study evaluates associations between serum vitamin D metabolites at diagnosis and one-year remission, in early diagnosed rheumatoid arthritis(RA). The CIMESTRA-cohort comprised 160 newly diagnosed RA patients, treated aiming at remission. Vitamin D supplementation was recommended according to na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herly, M., Stengaard-Pedersen, K., Vestergaard, P., Christensen, R., Möller, S., Østergaard, M., Junker, P., Hetland, M. L., Hørslev-Petersen, K., Ellingsen, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192905/ https://www.ncbi.nlm.nih.gov/pubmed/32355224 http://dx.doi.org/10.1038/s41598-020-64284-x

Ejemplares similares

Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes
por: Herly, M, et al.
Publicado: (2017)

Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis
por: Laustsen, Julie K, et al.
Publicado: (2014)

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients
por: Ammitzbøll, Christian Gytz, et al.
Publicado: (2014)

Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial
por: Møller-Bisgaard, Signe, et al.
Publicado: (2015)

Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis
por: Christensen, Anne Friesgaard, et al.
Publicado: (2010)

Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis
por: Pedersen, Janni Maria, et al.
Publicado: (2023)

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’
por: Greisen, Stinne Ravn, et al.
Publicado: (2014)

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
por: Kragstrup, Tue Wenzel, et al.
Publicado: (2016)

Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets
por: Issa, Saida Farah, et al.
Publicado: (2017)

The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
por: Kragstrup, Tue Wenzel, et al.
Publicado: (2016)

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
por: Nielsen, Morten A., et al.
Publicado: (2023)

Prevalence of Rheumatoid Arthritis in the Southern Part of Denmark
por: Pedersen, Jens K, et al.
Publicado: (2011)

Programmed death ligand 2 – A link between inflammation and bone loss in rheumatoid arthritis
por: Greisen, Stinne R., et al.
Publicado: (2019)

Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001
por: Pedersen, Jens K, et al.
Publicado: (2007)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Serial magnetic resonance imaging and ultrasound examinations demonstrate differential inflammatory lesion patterns in soft tissue and bone upon patient-reported flares in rheumatoid arthritis
por: Kuettel, Dorota, et al.
Publicado: (2020)

Can magnetic resonance imaging differentiate undifferentiated arthritis?
por: Østergaard, Mikkel, et al.
Publicado: (2005)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
por: Terslev, Lene, et al.
Publicado: (2021)

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial
por: Stockfelt, Marit, et al.
Publicado: (2021)

Rheumatoid Arthritis Relapse and Remission – Advancing Our Predictive Capability Using Modern Imaging
por: Terslev, Lene, et al.
Publicado: (2021)

Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study
por: Pedersen, Jens K, et al.
Publicado: (2014)

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study
por: Hendricks, Oliver, et al.
Publicado: (2019)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Whole-Body Magnetic Resonance Imaging Assessment of Joint Inflammation in Rheumatoid Arthritis—Agreement With Ultrasonography and Clinical Evaluation
por: Ng, Sin Ngai, et al.
Publicado: (2020)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial
por: Latocha, K. M., et al.
Publicado: (2020)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings
por: Greisen, Stinne R., et al.
Publicado: (2022)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Foot and Ankle Problems in Patients With Rheumatoid Arthritis in 2019: Still an Important Issue
por: Simonsen, Morten Bilde, et al.
Publicado: (2021)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Adherence to Methotrexate in Rheumatoid Arthritis: A Danish Nationwide Cohort Study
por: Bliddal, Henning, et al.
Publicado: (2015)

A non-synonymous single-nucleotide polymorphism in the gene encoding Toll-like Receptor 3 (TLR3) is associated with sero-negative Rheumatoid Arthritis (RA) in a Danish population
por: Laska, Magdalena J, et al.
Publicado: (2014)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Lee, Sook Yan, et al.
Publicado: (2021)

Methotrexate utilization in Rheumatoid arthritis. A register-based cohort-study of treatment re-starts after gabs of at least 90 days
por: de Thurah, Annette, et al.
Publicado: (2015)

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
por: Kapral, Theresa, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_akmp48nr3626uiidb63h4cl0cm